Karyopharm Therapeutics | PRE 14A:並購重組委托聲明
Karyopharm Therapeutics | 4:持股變動聲明-高管 Paulson Richard A.
Karyopharm Therapeutics | 8-K:重大事件
Karyopharm Therapeutics | 3:首次持股聲明-高管 Abate Kristin
Karyopharm Therapeutics | 8-K:重大事件
Karyopharm Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Avidity Partners Management LP(3.7%),Avidity Partners Management (GP) LLC(3.7%)等
Karyopharm Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(6.13%)
Karyopharm Therapeutics | 8-K:重大事件
Karyopharm Therapeutics | 4:持股變動聲明-高管 Paulson Richard A.
Karyopharm Therapeutics | S-8:員工福利計劃證券登記
Karyopharm Therapeutics | 10-Q:2024財年三季報
Karyopharm Therapeutics | 8-K:重大事件
Karyopharm Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(6.13%)
Karyopharm Therapeutics | 8-K:重大事件
Karyopharm Therapeutics | SC 13G:超過5%持股股東披露文件-Highbridge Capital Management, LLC(7.2%)
Karyopharm Therapeutics | 4:持股變動聲明-高管 Paulson Richard A.
Karyopharm Therapeutics | 8-K:重大事件
Karyopharm Therapeutics | 4:持股變動聲明-高管 Mano Michael
Karyopharm Therapeutics | 4:持股變動聲明-高管 Paulson Richard A.
Karyopharm Therapeutics | 4:持股變動聲明-高管 Mason Michael